Biofrontera shareholders elect directors and approve 5M share increase in incentive plan

Biofrontera Inc.

Elected Beth J. Hoffman and Kevin D. Weber as Class II directors until 2029; votes 8.09M and 8.20M for respectively.
Approved amendment to 2021 Omnibus Incentive Plan, increasing authorized shares from 3.75M to 8.75M; 7.89M for, 241K against.
Ratified CBIZ CPAs P.C. as independent auditor for FY2026; 10.9M for, 723K against.
Quorum of 11,630,133 votes present at June 11, 2026 Annual Meeting.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Biofrontera Inc. shareholders approved Approval of amendment and restatement of the Company's 2021 Omnibus Incentive Plan, including to increase the total number of shares of common stock authorized thereunder from 3,750,000 to 8,750,000. at the 2026-06-11 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2026-06-11

Exact text from the filing

Stockholders approved the amendment and restatement of the Company's 2021 Omnibus Incentive Plan, including to increase the total number of shares of common stock authorized thereunder from 3,750,000 to 8,750,000. The tabulation of votes cast was as follows: For Against Abstain Broker Non-Votes 7,893,236 241,359 175,881 3,319,657

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Biofrontera Inc. shareholders approved Ratification of appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-11 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-11

Exact text from the filing

Stockholders ratified the appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The tabulation of votes cast was as follows: For Against Abstain Broker Non-Votes 10,905,016 723,806 1,311 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Biofrontera Inc. shareholders approved Stockholders elected Beth J. Hoffman, Ph.D. and Kevin D. Weber to serve as Class II directors of the Company until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal. at the 2026-06-11 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-11

Exact text from the filing

Stockholders elected Beth J. Hoffman, Ph.D. and Kevin D. Weber to serve as Class II directors of the Company until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal. The tabulation of votes cast was as follows: Beth J. Hoffman, Ph.D. For Withheld Broker Non-Votes 8,089,416 221,060 3,319,657 Kevin D. Weber For Withheld Broker Non-Votes 8,203,433 107,043 3,319,657

View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Biofrontera Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-029079

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.